Simple clinical and laboratory features predict successful outcome of 131 I treatment of hyperthyroidism

males in the Graves’ disease group (21%) as compared with those with TNH (11.2%) (P<0.001). The 485 patients treated with a single 16-mCi dose of 131 I had a greater cure rate (84%) as compared with those treated with either 5 mCi(63%) or 10 mCi (75%) (P<0.001) (Figure 1). Within